Yea , I agree , this about the same type of patients lenzilumab is treating ,
I know 350 mg is less expensive , but this dose during the study makes me nervous.
When physicians treating patients later it is ok to try , but during study one cant change it ,
Well , we will see.
I will ask this question during next CC,,why ??
Market Data 
Markets 
AI
